Watch our on-demand, 45-minute panel discussion about how Deep Tech is shaping the venture capital landscape. Our four expert panelists will provide a nationwide perspective on the most cutting edge technologies that will influence our lives in the next 5-10 years. We will discuss forward-leaning technologies such as AI/Machine Learning, Biotech, Quantum Computing, Robotics, VR/AR/MR, Blockchain/Distributed Ledger, Advanced Materials and many more.
This presentation will be led by Lakeshore Ventures’ Managing Partner Justin Strausbaugh and will feature guests from the University of Chicago, Amazon, FedTech, and P33. Lakeshore Ventures is Alumni Ventures’ University of Chicago-focused venture capital fund.
*You must be accredited to invest in venture capital.
Michael Brett | Principal Specialist, Quantum Computing | Amazon Web Services (AWS)
Michael is a Principal Specialist for Quantum Computing in the High Performance Computing group at Amazon Web Services (AWS). In this role, he leads global business development and go to market efforts for Amazon Braket, a fully-managed quantum computing service in the cloud at AWS. He was previously SVP for Applications at Rigetti Computing, a quantum computing hardware company based in Berkeley, and CEO of QxBranch, a quantum computing applications start-up company acquired by Rigetti in 2019. Michael has a background in probabilistic risk modelling for aerospace applications and studied a Bachelor of Engineering in Aerospace Avionics and an Executive Master of Business in Complex Project Management, both from the Queensland University of Technology in Brisbane, Australia.
John Cole | Partner | FedTech
John is a engineer, entrepreneur, investor, and advisor. He has deep experience in software development and data science. He leverages 15 years of experience as an engineer, entrepreneur and technology leader in cleantech, robotics, and artificial intelligence. John started his career in energy, founding the clean biofuel production company United Biofuels, and serving as CEO. After his exit, he served in the US State Department in Iraq and Afghanistan, working with and advising local entrepreneurs and small businesses. His most recent tech venture in robotics was acquired by a Colorado robotics company. John is a partner at FedTech, a venture firm that launches startups based on deeptech technology. He leads the corporate ventures practice, connecting DeepTech portfolio companies into partnerships within the corporate world.
Dana Sun | Senior Associate | OCA Ventures
Dana Sun is a Senior Associate at OCA Ventures, a Chicago-based venture capital firm that invests in innovative core tech, fintech, and healthcare companies across the nation. At OCA, Dana focuses on investments in healthcare technology and services, and was a member of the deal team for eBlu Solutions, OssoVR, BioROSA, and iPill.
Previously, Dana was a strategic finance associate at Genentech in their Center of Financial Insights, which drove key commercial decisions across global affiliates. Before that, she was a management consultant at Accenture and primarily advised Fortune 500 healthcare clients including providers, payers, and biopharma companies on business & operations strategy.
Dana earned her MBA from the University of Chicago Booth School of Business and BSE in Biomedical Engineering from Duke University. Outside of work, she enjoys exploring the city with friends & family, playing tennis, and doing improv acting.
Zongxing Wang | Manager | Polsky Science Ventures at University of Chicago Polsky Center for Entrepreneurship and Innovation
Zongxing Wang, PhD is currently the manager of Polsky Science Ventures at the University of Chicago Polsky Center for Entrepreneurship and Innovation. In this role, he leads multiple efforts to commercialize advanced new deep technologies developed at the University of Chicago. He handles technology assessment, strategy formulation, and portfolio management.
Prior to joining Polsky, Zongxing Wang worked at ARCH Venture Partners to help source deals and evaluate investment opportunities. He also has experience working with a unicorn startup, Magic Leap, to help research and develop its first commercial product – Magic Leap 1. Dr. Wang has experience building startups ground-up as well. He successfully founded Neukit Corporation to commercialize a drug delivery particle and generated significant returns to his business partners. He won several awards for technology invention and commercialization, including SBIR grants from NIH and awards from philanthropy.
Zongxing earned his PhD in biomedical engineering from the University of Texas at Austin. He is currently finishing up an MBA at the University of Chicago Booth School of Business.
Zongxing is deeply passionate about commercializing technologies, especially those that bring profound social impacts and improve people’s lives. In his spare time, he enjoys reading, gardening, and spending time with his family.
Justin Strausbaugh | Managing Partner | Lakeshore Ventures
Before joining Alumni Ventures in 2021, Justin helped two corporate venture capital units achieve top-quartile returns. He has invested in companies across the U.S., Europe, and Israel from Seed stage to Series D and been the board observer for ten companies. Justin’s experience prior to entering venture capital was focused on the financial markets, where he traded derivatives in the global markets for eight years and then co-founded a financial markets education and research business. Justin is a former college and professional golfer, competing in over 40 professional tournaments and participating in the PGA Tour’s qualifying school. He and his wife are both proud graduates of the University of Chicago Booth School of Business.